New ways viruses affect human immune response discovered

August 3, 2012

(Medical Xpress) -- New ways that viruses manipulate the human immune response have been revealed in a research paper just published in Nature involving TCD scientists. Dr Orla Mulhern and Professor Andrew Bowie, School of Biochemistry and Immunology based in the Trinity Biomedical Sciences Institute were part of the multi-disciplinary, multi-centre study comprising immunologists, virologists, biochemists and bioinformaticians from across Europe.

This research is the most comprehensive study to date analysing strategies used by over 30 viruses to target defence networks in human cells, and provides many new insights into how viruses seek to avoid and weaken the immune response. The research findings could ultimately lead to the development of broad and specific antiviral therapies and new ways to treat patients with infectious diseases.

Scientists at the Centre for Molecular Medicine of the Austrian Academy of Sciences (CeMM) gathered 70 viral genes known to modulate the immune response from collaborators across Europe, including Trinity, and systematically inserted these genes into human cells. The genes were derived from 30 different viruses, including poxviruses, herpesviruses, and . They then used to identify all the human proteins targeted by the products of the inserted genes, and bioinformatics to comprehensively analyse the viral- interactions. Collaborating labs, including Trinity, then verified and validated some of the most exciting new viral-human interactions discovered. 

Commenting on the significance of the research, Professor Bowie, Head of Immunology, School of Biochemistry and Immunology, TCD stated: “The data shows that viruses target a much wider array of cellular processes than was previously anticipated. At least some of these cellular processes will have important but previously unrecognised anti-viral roles. Thus follow-on studies in our lab and others will reveal new anti-viral immune defences operating in human cells. Also since we could identify both common and unique targets for viruses in cells, future work will also help towards designing antiviral therapies both for specific viruses and for broad classes of viruses.”

Explore further: Big picture of how interferon-induced genes launch antiviral defenses revealed

More information: Pichlmair, A., Kandasamy, K., Alvisi, G., Mulhern, O., Sacco, R., Habjan, M., Binder, M., Stefanovic, A., Eberle, C., Goncalves, A., Bürckstümmer, T., Müller, A., Fauster, A., Holze, C., Lindsten, K., Goodbourn, S., Kochs, G., Weber, F., Bartenschlager, R., Bowie, A.G., Bennett, K.L., Colinge, J. & Superti-Furga, G. 2012. Viral immune modulators perturb the human molecular network by common and unique strategies. Nature 487, 486-490.

Related Stories

Big picture of how interferon-induced genes launch antiviral defenses revealed

April 10, 2011
When viruses attack, one molecule more than any other fights back. Interferon triggers the activation of more than 350 genes, and despite the obvious connection, the vast majority have never been tested for antiviral properties. ...

Recommended for you

Discovery of potent parasite protein may lead to new therapeutic options for inflammatory bowel conditions

November 24, 2017
A single protein from a worm parasite may one day offer new therapeutic options for treating inflammatory bowel diseases like Crohn's or Ulcerative Colitis, that avoid the potentially serious side effects of current immunosuppressant ...

Druglike molecules produced by gut bacteria can affect gut, immune health

November 23, 2017
Stanford researchers found that manipulating the gut microbe Clostridium sporogenes changed levels of molecules in the bloodstreams of mice and, in turn, affected their health.

Study explores whole-body immunity

November 21, 2017
Over the next few months, millions of people will receive vaccinations in the hope of staving off the flu—and the fever, pain, and congestion that come with it.

Drug could cut transplant rejection

November 21, 2017
A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs, according to new research by Queen Mary University of London ...

Atopic eczema—one size does not fit all

November 21, 2017
Researchers from the UK and Netherlands have identified five distinct subgroups of eczema, a finding that helps explain how the condition can affect people at different stages of their lives.

Breast milk found to protect against food allergy

November 20, 2017
Eating allergenic foods during pregnancy can protect your child from food allergies, especially if you breastfeed, suggests new research from Boston Children's Hospital. The study, published online today in the Journal of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.